Development of NKG2D chimeric antigen receptor-T cells as targeted therapy of liver cancer

被引：3
|
作者：
Dai, Hong-jiu
Yang, Dong
Sun, Bin
Jiang, Yu-Bo
Jia, Ru
Xu, Jian-Ming
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NKG2D chimeric antigen receptor-T cells to target GBM.
    Dai, Hong-jiu
    Yang, Dong
    Sun, Bin
    Shi, Lan
    Zhang, Pei-xian
    Zhao, Xu-dong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Tao, Kelong
    He, Meng
    Tao, Feng
    Xu, Guangen
    Ye, Minfeng
    Zheng, Yuanyuan
    Li, Yaoqing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 815 - 827
  • [3] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Kelong Tao
    Meng He
    Feng Tao
    Guangen Xu
    Minfeng Ye
    Yuanyuan Zheng
    Yaoqing Li
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 815 - 827
  • [4] Chimeric antigen receptor T cell therapy targeting NKG2D ligand
    Asao, Tetsuhiko
    Ishibashi, Rie
    Inoue, Moeko
    Fuse, Masafumi
    Miura, Yoshie
    Ishizaki, Hidenobu
    Yoshimura, Kiyoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
    Jie Xu
    Qingtao Meng
    Hao Sun
    Xinwei Zhang
    Jun Yun
    Bin Li
    Shenshen Wu
    Xiaobo Li
    Hongbao Yang
    Haitao Zhu
    Michael Aschner
    Michela Relucenti
    Giuseppe Familiari
    Rui Chen
    Cell Death & Disease, 12
  • [6] HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
    Xu, Jie
    Meng, Qingtao
    Sun, Hao
    Zhang, Xinwei
    Yun, Jun
    Li, Bin
    Wu, Shenshen
    Li, Xiaobo
    Yang, Hongbao
    Zhu, Haitao
    Aschner, Michael
    Relucenti, Michela
    Familiari, Giuseppe
    Chen, Rui
    CELL DEATH & DISEASE, 2021, 12 (12)
  • [7] T cells expressing an NKG2D chimeric antigen receptor efficiently eliminate glioblastoma cells and cancer stem cells
    Yang, D.
    Sun, B.
    Dai, H.
    Zhao, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1712 - 1713
  • [8] Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer
    Zhang, Yipeng
    Liang, Kaijie
    Zhou, Xiaoyu
    Zhang, Xin
    Xu, Hui
    Dai, Hongjiu
    Song, Xueru
    Yang, Xueyi
    Liu, Baorui
    Shi, Tao
    Wei, Jia
    CANCER SCIENCE, 2023, 114 (07) : 2798 - 2809
  • [9] A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma
    Nikiforow, Sarah
    Murad, Joana
    Daley, Heather
    Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Lehmann, Frederic
    Snykers, Sarah
    Allen, Rachel
    Galinsky, Ilene
    Munshi, Nikhil C.
    Stone, Richard M.
    Soiffer, Robert
    Ritz, Jerome
    Baumeister, Susanne H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
    Murad, Joana M.
    Baumeister, Susanne H.
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Gilham, David
    Lehmann, Frederic
    Snykers, Sarah
    Sentman, Marie-Louise
    Wade, Terri
    Schmucker, Adam
    Fanger, Michael W.
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CYTOTHERAPY, 2018, 20 (07) : 952 - 963
12345